Who we are
Biozeus has the expertise to develop cutting-edge brazilian pharmaceuticals to the world
Our Technology
Biozeus main technology is derived from the Brazilian Biodiversity
and is classified as a new therapeutic class
Biozeus has the expertise to develop cutting-edge brazilian pharmaceuticals to the world
Biozeus main technology is derived from the Brazilian Biodiversity
and is classified as a new therapeutic class
Biozeus is a clinical-stage biotech company that transforms academic discoveries into innovative therapies.
We advance promising compounds from preclinical to clinical development, bridging the gap between early-stage research and the market.
Founded in 2012 and backed by Brazilian venture capital, Biozeus combines scientific expertise and strategic management to identify, in-license, and develop high-potential drug candidates.
Through a disciplined Go/No-Go decision process, only projects with strong scientific and commercial potential move forward to pivotal clinical stages.
At Biozeus, we transform academic discoveries into innovative medicines that improve and save lives worldwide.
As Brazil’s leading biotech in translational drug development, we bridge the gap between promising university research and the pharmaceutical industry — connecting publicly funded science, government and private investment, and global biotech expertise.
We are driven by a clear goal: to overcome one of the greatest challenges in life sciences — turning groundbreaking academic research into therapies that truly reach patients and make a difference.
Please subscribe to receive important Biozeus news.
Usamos cookies para analisar o tráfego do site e otimizar sua experiência nele. Ao aceitar nosso uso de cookies, seus dados serão agregados com os dados de todos os demais usuários.